[Immunoscintigraphy in inflammatory and malignant diseases. anti-leukocyte and anti-tumor antibodies].
Antibody-labelled granulocytes, antigranulocyte antibodies and radiolabelled immunoglobulin can reliably visualize foci of infection; their use in urologic inflammatory disorders is rare. In the diagnosis of urologic tumours anti-CEA immunoscintigraphy of urinary bladder cancer seems to be superior to conventional imaging techniques in sensitivity and specificity. Experience with immunoscintigraphy in non-seminomatous germ cell tumours and prostate cancer are limited; immunoscintigraphy of renal cell cancer is still in the experimental stage in clinical medicine.
Kramer
W
W
Klinik für Urologie, Johann-Wolfgang-Goethe-Universität, Frankfurt/Main.
Baum
R P
RP
Hör
G
G
Jonas
D
D
D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm / Q000276:immunology; D006801:Humans; D007962:Leukocytes / Q000276:immunology; D016719:Radioimmunodetection; D014552:Urinary Tract Infections / Q000000981:diagnostic imaging*; D014565:Urogenital Neoplasms / Q000000981:diagnostic imaging*
D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm
Immunszintigraphie bei entzündlichen und malignen Erkrankungen. Antileukozyten und Antitumorantikörper.